全文获取类型
收费全文 | 30010篇 |
免费 | 2163篇 |
国内免费 | 50篇 |
专业分类
耳鼻咽喉 | 277篇 |
儿科学 | 884篇 |
妇产科学 | 922篇 |
基础医学 | 3654篇 |
口腔科学 | 420篇 |
临床医学 | 6308篇 |
内科学 | 5222篇 |
皮肤病学 | 322篇 |
神经病学 | 2717篇 |
特种医学 | 494篇 |
外国民族医学 | 2篇 |
外科学 | 2586篇 |
综合类 | 378篇 |
一般理论 | 42篇 |
预防医学 | 3971篇 |
眼科学 | 367篇 |
药学 | 1746篇 |
中国医学 | 25篇 |
肿瘤学 | 1886篇 |
出版年
2023年 | 165篇 |
2022年 | 250篇 |
2021年 | 527篇 |
2020年 | 353篇 |
2019年 | 549篇 |
2018年 | 625篇 |
2017年 | 488篇 |
2016年 | 573篇 |
2015年 | 697篇 |
2014年 | 974篇 |
2013年 | 1403篇 |
2012年 | 1881篇 |
2011年 | 1865篇 |
2010年 | 1075篇 |
2009年 | 1062篇 |
2008年 | 1802篇 |
2007年 | 1743篇 |
2006年 | 1722篇 |
2005年 | 1766篇 |
2004年 | 1621篇 |
2003年 | 1587篇 |
2002年 | 1540篇 |
2001年 | 406篇 |
2000年 | 359篇 |
1999年 | 465篇 |
1998年 | 471篇 |
1997年 | 438篇 |
1996年 | 448篇 |
1995年 | 425篇 |
1994年 | 387篇 |
1993年 | 316篇 |
1992年 | 353篇 |
1991年 | 309篇 |
1990年 | 312篇 |
1989年 | 253篇 |
1988年 | 239篇 |
1987年 | 234篇 |
1986年 | 176篇 |
1985年 | 195篇 |
1984年 | 202篇 |
1983年 | 156篇 |
1982年 | 192篇 |
1981年 | 147篇 |
1980年 | 139篇 |
1979年 | 135篇 |
1978年 | 131篇 |
1977年 | 84篇 |
1976年 | 95篇 |
1975年 | 84篇 |
1973年 | 90篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
3.
Judith Brock Andreas Schmid Thomas Karrasch Petra Pfefferle Jutta Schlegel Inga Busse Annette Hauenschild Barbara Schmidt Maria Koukou Efthymia Arapogianni Andreas Schultz Miriam Thomalla Secil Akinci Johannes Kruse Winfried Padberg Andreas Schffler Jens Albrecht 《Clinical endocrinology》2019,91(3):400-410
4.
Patients have become increasingly well informed with higher expectations to be involved in decision-making processes regarding their care and treatment. However, few studies have examined the impact of patient involvement on health care providers’ partnership-building communication. The aim of this study was to measure and explore the self-reported effects of patient involvement on the work of physicians and nurses. A questionnaire survey was distributed among cardiology staff in 12 Swedish hospitals (N = 488, response rate 67%). The sample was comprised of registered nurses (RNs, n = 303), licensed practical nurses (LPNs, n = 132), and physicians (MDs, n = 53). Confirmatory factor analysis was used to examine seven questionnaire statements concerning implications of patient involvement for one’s clinical work. Regression analyses were used to examine factors associated with staff’s partnership-building communication. Analysis confirmed two distinct factors accounting for 57% of the total variance, representing both negative—“Hassles”—and positive—“Uplifts”—aspects of patient involvement. Regression analyses revealed that only positive aspects (i.e., uplifts) of patient involvement predicted staff behavior aimed at involving patients. Working with actively involved patients may be a source of stress, both negative and positive, for health care professionals. By developing work routines for involving patients in their care, health care workplaces may help health care professionals to buffer the negative effects, and enhance the positive effects, of that stress. 相似文献
5.
6.
Implications for Practice
Breast cancer is far more curable than in the past but requires multimodality treatment. Great care must be taken to use the least leukemogenic treatment programs that do not sacrifice efficacy. Elimination of radiation and anthracycline/alkylating agent regimens will be helpful where possible, particularly in younger patients and possibly those with homologous repair deficiency (HRD). Use of colony-stimulating factors should be limited to those who truly require them for safe chemotherapy administration. Further study of a possible leukemogenic association with HRD and the various forms of colony-stimulating factors is badly needed.7.
Recognizing and managing a deteriorating patient: a randomized controlled trial investigating the effectiveness of clinical simulation in improving clinical performance in undergraduate nursing students
下载免费PDF全文
![点击此处可从《Journal of advanced nursing》网站下载免费的PDF全文](/ch/ext_images/free.gif)
8.
9.
Susan C. Fox Jane A. May Natalia Dovlatova Jackie R. Glenn Andrew Johnson Ann E. White 《Platelets》2019,30(3):290-295
Measurement of P-selectin on activated platelets as a means of measuring platelet function utilizing the technology described here has the advantage of not requiring immediate access to specialist equipment and expertise. Blood samples are activated, fixed, stored, and transported to a central laboratory for flow cytometric analysis. Here we have compared P-selectin with other more traditional approaches to measuring platelet function in blood and/or platelet-rich plasma (PRP) from patients with acute coronary syndromes on treatment for at least 1 month with either aspirin and clopidogrel or aspirin with prasugrel. The comparators were light transmission aggregometry (LTA), VerifyNow and Multiplate aggregometry (for determining the effects of aspirin) and LTA, VerifyNow and Multiplate together with the BioCytex VASP phosphorylation assay (for the P2Y12 antagonists). The P-selectin Aspirin Test revealed substantial inhibition of platelet function in all but three of 96 patients receiving aspirin with clopidogrel and in none of 51 patients receiving aspirin and prasugrel. The results were very similar to those obtained using LTA. There was only one patient with high residual platelet aggregation and low P-selectin expression. The same patients identified as “non-responders” to aspirin also presented with the highest residual platelet activity as measured using the VerifyNow system, although not quite as well separated from the other values. With the Multiplate test only one of these patients clearly stood out from the others. The results obtained using the P-selectin P2Y12 Test in 102 patients taking aspirin and clopidogrel were similar to the more traditional approaches in that a wide scatter of results was obtained. Generally, high values seen with the P-selectin P2Y12 Test were also high with the LTA, VerifyNow, Multiplate, and BioCytex VASP P2Y12 Tests. Similarly, low residual platelet function using the P2Y12 test was seen irrespective of the testing procedure used. However, there were differences in some patients. Prasugrel was always more effective than clopidogrel in inhibiting platelet function with none of 56 patients (P-selectin and VerifyNow), only 2 of 56 patients (Multiplate) and only 3 of 56 patients (Biocytex VASP) demonstrating high on-treatment residual platelet reactivity (HRPR) defined using previously published cut-off values. The exception was LTA where there were 11 of 56 patients with HRPR. It remains to be seen which experimental approach provides the most useful information regarding outcomes after adjusting therapies in treated patients. 相似文献
10.
C. Jacquet F. Goehringer E. Baux J.A. Conrad M.O. Ganne Devonec J.L. Schmutz G. Mathey H. Tronel T. Moulinet I. Chary-Valckenaere T. May C. Rabaud 《Médecine et maladies infectieuses》2019,49(2):112-120